Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Razelle Kurzrock Funda Meric-Bernstam Mariana Chavez-MacGregor Filip Janku |
| Publication date | November 23, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |